APA-referens

Shuttleworth, S., Silva, F., Cecil, A., Tomassi, C., Hill, T., Raynaud, F., . . . Workman, P. (2011). Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors. Bentham Science Publishers Ltd.

Chicago-stil citat

Shuttleworth, S.J, F.A Silva, A.R.L Cecil, C.D Tomassi, T.J Hill, F.I Raynaud, P.A Clarke, och P. Workman. Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors. Bentham Science Publishers Ltd, 2011.

MLA-referens

Shuttleworth, S.J, et al. Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors. Bentham Science Publishers Ltd, 2011.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.